AR114997A2 - HUMANIZED ANTI-FACTOR D ANTIBODIES AND THEIR USES - Google Patents

HUMANIZED ANTI-FACTOR D ANTIBODIES AND THEIR USES

Info

Publication number
AR114997A2
AR114997A2 ARP180103880A ARP180103880A AR114997A2 AR 114997 A2 AR114997 A2 AR 114997A2 AR P180103880 A ARP180103880 A AR P180103880A AR P180103880 A ARP180103880 A AR P180103880A AR 114997 A2 AR114997 A2 AR 114997A2
Authority
AR
Argentina
Prior art keywords
antibodies
factor
humanized anti
diseases
treatment
Prior art date
Application number
ARP180103880A
Other languages
Spanish (es)
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of AR114997A2 publication Critical patent/AR114997A2/en

Links

Abstract

La presente hace referencia a anticuerpos anti-factor D, sus secuencias de aminoácidos y ácidos nucleicos, las células y vectores que contienen estos anticuerpos y su producción y uso en la preparación de composiciones y medicamentos para el tratamiento de enfermedades y trastornos asociados a una activación excesiva o descontrolada del complemento. Estos anticuerpos son útiles para diagnóstico, prevención y tratamiento de enfermedades.This refers to anti-factor D antibodies, their amino acid and nucleic acid sequences, the cells and vectors that contain these antibodies and their production and use in the preparation of compositions and medicaments for the treatment of diseases and disorders associated with activation. excessive or uncontrolled complement. These antibodies are useful for the diagnosis, prevention and treatment of diseases.

ARP180103880A 2008-04-28 2018-12-27 HUMANIZED ANTI-FACTOR D ANTIBODIES AND THEIR USES AR114997A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4843108P 2008-04-28 2008-04-28

Publications (1)

Publication Number Publication Date
AR114997A2 true AR114997A2 (en) 2020-11-18

Family

ID=51586758

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP180103880A AR114997A2 (en) 2008-04-28 2018-12-27 HUMANIZED ANTI-FACTOR D ANTIBODIES AND THEIR USES

Country Status (2)

Country Link
AR (1) AR114997A2 (en)
UA (1) UA100888C2 (en)

Also Published As

Publication number Publication date
UA100888C2 (en) 2013-02-11

Similar Documents

Publication Publication Date Title
CR11817A (en) ANTI-FACTOR D HUMANIZED ANTIBODIES AND THEIR USES
AR063760A1 (en) ANTI-FACTOR D HUMANIZED ANTIBODIES AND USES OF THE SAME
CR11837A (en) IMMUNOGLOBULINS WITH DUAL VARIABLE DOMAIN AND USES OF THE SAME
GT201200058A (en) IMMUNOGLOBULINS WITH DUAL VARIABLE DOMAIN AND USES OF THE SAME
CR20110631A (en) IMMUNOGLOBULIN WITH DUAL VARIABLE DOMAIN AND USES OF THE SAME
UY31861A (en) IMMUNOGLOBULIN WITH DUAL VARIABLE DOMAIN AND USES OF THE SAME
CR20180233A (en) OLIGONUCLEOTID COMPOSITIONS AND THEIR METHODS
CL2017002767A1 (en) New specific proteins for cd137.
AR092779A1 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES ANTIBODIES THAT JOIN TAU PROTEIN CONFORMERS
CR20110509A (en) PHARMACEUTICAL COMPOSITION
BR112013026114A2 (en) nutritional compositions including branched chain fatty acids and processes for using them
AR090465A1 (en) SOLID FORMS OF A THIOPHOSPHORAMIDATE NUCLEOTIDE PROFARMACO
ECSP13012609A (en) PHARMACEUTICAL COMPOSITION
CO6680687A2 (en) Dual variable domain immunoglobins capable of binding to il 1 beta and il-17, pharmaceutical compositions and protein binding conjugates thereof
UY32883A (en) HUMAN HIGH AFFINITY ANTIBODIES AGAINST THE RECEPTOR ACTIVATED BY HUMAN TYPE 2 PROTEASE
CL2021000207A1 (en) New fusion proteins specific for cd137 and pd-l1
BR112015023603A2 (en) methods of using zscan4 to rejuvenate human cells
BR112013031084A2 (en) Means and Methods for Active Cellular Cancer Immunotherapy Using High Hydrostatic Pressure-killed Tumor Cells and Dendritic Cells
CL2017000382A1 (en) Substituted bicyclic compounds
EA201690191A1 (en) PHARMACEUTICAL COMPOSITION FOR THE SLOWLY RELEASE OF LANREOTIDE
CL2008001690A1 (en) Compounds derived from oxazolidinones; its preparation procedure; and its uses to prepare a medicine.
AR114997A2 (en) HUMANIZED ANTI-FACTOR D ANTIBODIES AND THEIR USES
AR115878A1 (en) SPECIFIC FUSION PROTEINS FOR CD137 AND PD-L1
BR112018005943A2 (en) modified release oral administration amino acid formulations
CY1117058T1 (en) HUMANIZED ANTI-FACTOR ANTIBODIES